Buzz Pocket

Thursday, July 29, 2021

Future Growth: Health and Wellness Market Anticipated for Progressive CAGR Growth During 2020-2027

The global market for health and wellness is anticipated to account for $6,543.4 million in 2026, at a 4.8% CAGR increasing from $4,514.3 million in 2018.

The significant drivers for the health and wellness market are increasing demand for health spas and mineral & thermal springs centers globally. Moreover, thermal and mineral springs have several therapeutic benefits including boosting blood circulation, reducing stress, relieving pain, healing skin diseases and afew other benefits. Also, taking frequent baths in thermal springs can reduce 46% of hypertension; this aspect will eventually boost the health and wellness market growth in the upcoming years. However, the huge expenditure is essential for the launching and maintaining of mineral & thermal springs and health spas, and these are key restraints for the global market size. In addition, price of the health and wellness products is also expected to hinder the market size.Increasing awareness among people about organic products and growing knowledge on sustainable products will create vast opportunities for the health and wellness market growth in the coming years.

For More Detail Insights, Download FREE Sample Copy of the Report at: https://www.researchdive.com/download-sample/152

The beauty & personal care product type accounted for the highest health and wellness market size in 2018 and is projected to grow at a rate of 4.5% CAGR during the estimated timeframe. The wellness tourism segment is anticipated to raise at a noteworthy rate of 4.8% CAGR and is expected to endure its growth throughout the forecast time. This expected growth is mainly because of swift growth in the wellness tourism in hospitality sector, and it is playing a significant role in attracting tourists. Due to advantages of wellness tourism, growing adoption of wellness tourism by the hotels, resorts and tourist destinations to entertain tourists is anticipated to drive the market size in the forecast timeframe.

The global health and wellness market share was dominated by the North America region in 2018, with a size of $1,793.6 million in 2018. This is projected to generate a revenue of $2,519.2 million till 2026. This dominance in the current market is because of extensive utilization of health and wellness products and services in developed economies including Canada and U.S. Asia-Pacific market. The markets in these regions will experience a noteworthy growth, it is projected to generate a significant revenue and create substantial growth opportunities during the forecast time. This growth is accredited to rising consciousness about health and wellness services and products prominence amongst the individuals in Asia-Pacific. In addition, existence of promising government initiatives coupled with growing need of health and wellness products are promoting the market in Asia-Pacific region.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/152

Some of the significant health and wellness market players include LifeScan, Medtronic, L’Oréal, Abbott, General Mills Inc., B. Braun Melsungen AG, Nestlé, Koninklijke Philips N.V., Omron Healthcare, Inc., The Coca-Cola Company, Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd, Animas LLC and many others. These major participants are following several approaches such as product developments, acquisitions, joint ventures and R&D activities to achieve top spots in the overall health and wellness industry.

Porter’s Five Forces Analysis for Health and Wellness Market:

• Bargaining Power of Suppliers: The established suppliers in the health and wellness market utilize their switching influence to gain high costs. Furthermore, the transferring costs from supplier to supplier is predicted to be high.
The negotiating power of suppliers is HIGH.

• Bargaining Power of Purchaser: The market has huge number of consumers and requirement of health and wellness services and products are rising rapidly.
The negotiating power of consumers is HIGH.

• Threat of New Entrants: High cost associated for maintenance and installation coupled with government regulatory restrictions, provides the low threat of new entrants in the market.
The threat of new entrants is LOW.

• Threat of Substitutes: This market contains very low substitute products and services, delivers low treat of substitutes.
The threat of alternatives is LOW.

• Competitive Rivalry in the Market: Health and wellness market contains several small&medium, and large manufacturers. Leading manufacturers are implementing various approaches such as product developments, technological advancements and joint ventures. These are common strategies followed by manufacturers, is a major factor for the high competitive rivalry in the global health and wellness market.
The competitive rivalry in the industry is HIGH.

Top Trending Reports of 2020-
1. Plant-based Biologics Market – https://www.researchdive.com/150/plant-based-biologics-market
2. Private Nursing Services Market – https://www.researchdive.com/95/private-nursing-services-market
3. Coagulation Testing Market – https://www.researchdive.com/86/coagulation-testing-market

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
Free : +1 -888-961-4454
Email: support@researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Competitive Scenario: Intraoperative Neuromonitoring Market Expected to Witness Rapid Expansion by the End of 2027

According to Intraoperative Neuromonitoring Market Analysis by Research Dive, the global market forecast will be $3,413.0 million by the end of 2026, at a 4.5% CAGR, growing from $2,400.0 million in the end of 2018.

Intraoperative Neuromonitoring Market Drivers: Growing aged populace globally, along with increasing occurrence of chronic illnesses, are the major driving aspects for the intraoperative neuromonitoring market growth. Furthermore, intraoperative monitoring is an important process that assists in risk management throughout complex surgeries. This factor is projected to propel the market size in the coming years. Furthermore, rising trend of medical tourism along with growing investments for healthcare infrastructure in developing economies are projected to create significant revenue generating opportunities in the global market. Nevertheless, shortage of trained workforce for the control and maintenance of intraoperative neuromonitoring arrangements are limiting the market size growth. Moreover, lack of awareness on intraoperative neuromonitoring specifically in developing economies is also one of the factors restricting the market size.

For More Detail Insights, Download FREE Sample Copy of the Report at: https://www.researchdive.com/download-sample/162

Intraoperative neuromonitoring market for insourced type generated for highest market size, it was valued at $1,401.6 million in the 2018 and is projected to continue its trend in the estimated time. This growth is mainly owing to growing number of surgeries and wide usage of insourced monitoring by hospitals across the globe. The market for outsourced monitoring type is anticipated to rise at a notable rate and is expected to reach $1,658.7 million till 2026. This is mainly because healthcare centers and hospitals are shifting towards outsourced monitoring type owing to its less cost compared to insourced monitoring.

The neuro & spine surgeries intraoperative neuromonitoring market registered $830.4 million in 2018 and is estimated to continue its growth & command over global market throughout the forecast time. The dominance is significantly due to growing demand for intraoperative neuromonitoring for constant monitoring of neuro & spinal surgery processes. Moreover, intraoperative neuromonitoring arrangements are able to identify an unsuspected & unpleasant neurological fault after neuro & spinal surgeries; this aspect will boost the growth of the market. The intraoperative neuromonitoring market for orthopedic surgeries application will witness to rise at a CAGR of 5.4% and is estimated to account for $921.5 million in 2026. This growth is owing to growing adoption of intraoperative neuromonitoring for the orthopedic surgeries.

North America has dominated the global intraoperative neuromonitoring market size in the previous years followed by Europe and is estimated to grow at a rate of 3.8% CAGR in the projected time. This command over global market is mainly due to well-established healthcare structure in this region. Moreover, increasing awareness among people about intraoperative neuromonitoring is also anticipated to boost the market growth in North America region. Asia-Pacific intraoperative neuromonitoring market is projected to experience a notable growth and is estimated to generate substantial revenue opportunities in the projected timeframe. Growing number of neurological surgeries and rising funds on development of healthcare sector is projected to drive the growth of the market.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/162

NuVasive, Inc., NIHON KOHDEN CORPORATION, Computational Diagnostics, Inc., Moberg Research, Inc., Cadwell Industries, Inc., Medsurant Health, Medtronic, IntraNerve Neuroscience Holdings, LLC, Medgadget, Inc., Accurate Monitoring, NeuroMonitoring Technologies, Inc. are some of the global intraoperative neuromonitoring market players. These significant players are emphasizing on new product launches, geographical expansions and collaborations & partnerships; these are some of the strategies to gain majority of the market share in the global intraoperative neuromonitoring industry.

Porter’s Five Forces Analysis for Intraoperative Neuromonitoring Market:

• Bargaining Power of Suppliers: The intraoperative neuromonitoring market contains high number of large and small & medium suppliers and growing demand for intraoperative neuromonitoring systems, and hence, the resulting bargaining power of suppliers is HIGH.

• Bargaining Power of Consumers: Intraoperative neuromonitoring market has huge number of consumers and consumer can check the prices of several intraoperative neuromonitoring arrangements manufacturers. The bargaining power of consumer is HIGH.

• Risk of New Entrants: Intraoperative neuromonitoring market has key players and strict government guidelines on the authorization of intraoperative neuromonitoring procedures, which is resulting in HIGH risk of new contestants in the industry.

• Risk of Substitutes: This market contains very a smaller number of alternative solutions, and thereby, there is LOW risk of alternatives.

• Competitiveness in the Industry: Intraoperative neuromonitoring market has large number of key manufacturers. These key players are concentrating on mergers, joint ventures, R&D investments and new product launches to raise position in the global market. This aspect is delivering HIGH competitiveness in the industry.

Top Trending Reports of 2020-
1. Health and Wellness Market – https://www.researchdive.com/152/health-and-wellness-market
2. Plant-based Biologics Market – https://www.researchdive.com/150/plant-based-biologics-market
3. Private Nursing Services Market – https://www.researchdive.com/95/private-nursing-services-market

Contact Us:

Growth Outlook: Computer-Aided Drug Discovery Market Is Projected to Grow at a Substantial Rate by 2027 - Report by ResearchDive

According to a study conducted by Research Dive, the global computer-aided drug discovery market forecast size is expected to reach $4,878.5 billion by the end of 2026, registering 15.5% CAGR over the forecast period.

Computer-aided drug design utilizes computational methods to analyze, develop, and discover similar biologically active molecules. The ligand-based computer-aided drug discovery (LB-CADD) method includes the understanding of ligands which are known to interrelate with a targeted disease. These procedures use a set of referral structures that are collected from compounds known to interact with the target of interest and analyze their 2D or 3D structures.

Download FREE Sample Copy of the Report at: https://www.researchdive.com/download-sample/159

The rising usage of pharmaco dynamics and pharmaco kinetic modelling in pre-clinical advancements is anticipated to drive the computer-aided drug discovery market’s growth in the recent years. In addition, the rapid growth in the demand for latest technologies to decrease the cost associated with drug discovery and development is the major factor for the growth of computer-aided drug discovery market.

Inspite of various positive factors, improper standardization in the drug discovery methodology has been a major point of concern. Along with the afore mentioned factor, insufficient knowledge about various biological systems and processes due to which the drug development fails are the major factor that may hamper the market growth.

The global computer-aided drug discovery market is analyzed on the basis of type into Structure based drug design (SBDD), Ligand-Based Drug Design (LBDD) and Sequence-Based Approaches. Among these, the structure-based drug design market segment is expected to drive the computer-aided drug discovery market growth which is anticipated to reach $1,585.5 billion by 2026, growing at CAGR of 15.8% during the forecast period. However, LBDD segment had the highest market share in the year 2018 accounting for $606.9 billion and is expected to reach $1,878.2 billion by 2026 growing ata CAGR of 15.2% during the projected timeframe. This dominance is mainly attributed to the usage of LBDD that is the first step in developing any drug and understanding a disease molecular structure, and developing a drug suitable to resist the disease is a time taking process.

On the basis of the therapeutic area, the global computer-aided drug discovery market is categorized into oncology, neurology, cardiovascular disease, respiratory disease and diabetes and others. Among these, the market for oncology segment held the largest market share in 2018 accounting for $355.8 billion. Cardiovascular diseases segment is anticipated to dominate the computer-aided drug discovery market during the forecaste period. This is because the number of patients suffering from cardiovascular diseases globally is increasing. Thus, to fight the various cardio vascular diseases, the key players are investing huge in developing better and enhanced drugs.

The global computer-aided drug discovery market has been classified regionally into North America, Europe, Asia-Pacific, and LAMEA.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/159

The North America region held the largest market value in 2018 accounting for $432.9 billion and is anticipated to reach $1,283.1 billion by 2026, growing at a CAGR of 14.5% during the forecast period. Asia-Pacific region is expected to dominate the computer-aided drug discovery market; this growth is majorly due to the growing R&D expenditure by the organizations that are present in this region. The number of people suffering from various diseases in this region is also growing due to the lack of money to buy costly medicines. Asia-Pacific region accounted for $411.3 billion in 2018 and is expected to reach $1,361.1 billion by 2026, growing at a CAGR of 16.1% during the forecast period.

Top gaining participants of global computer-aided drug discovery market are BOC Sciences, Schrödinger, Aragen Bioscience, AstraZeneca, Albany Molecular Research Inc. (AMRI), BioDuro, Aris Pharmaceuticals, Charles River, Evotec A.G. and Bayers AGamong many others. These key participants are concentrating on product improvements, mergers & acquisitions, collaborations and new product launches to gain majority of the market share in the overall Computer-Aided Drug Discovery industry.

Porter’s Five Forces Analysis for Computer-Aided Drug Discovery Market:

1. Bargaining Power of Suppliers: The key players present in this market arelimited and are catering the demand of computer-aided drug discovery due to which the supplier’s power is High.

2. Bargaining Power of Consumers: The number of consumers is very highand thus the bargaining power of consumers is Low.

3. Threat of new entrants: Initial investment to setup a computer-aided drug discovery organization is very high and thus the threat of new entrants is Low.

4. Threat of substitutes: There is no alternative for computer-aided drug discovery, and thus the threat of substitutes is Low.

5. Competitive rivalry in the industry: This market includes a few market participants. Many of the key players are following similar strategies for the improvement of technologies.
The competitive rivalry in the industry is High.

Contact Us:

Top Scenario: Medical Device Manufacturing Outsourcing Market 2020 to Witness Excellent Long-Term Growth Outlook - Report by ResearchDive

According to a study of Research Dive, the global medical device manufacturing outsourcing market forecast shall cross $104.3 million by 2026, growing at a CAGR of 10.3%.

The significant medical contract manufacturers mainly design and manufacture medical devices along with the provided services such as UV bonding, injection molding, and other manufacturing services to the larger-sized OEMs and medical device companies. Massive increase in the geriatric population,growing global demand for the life expectancy and tremendously booming demand for technological advances particularly in the medical device industries, are some of the key factors projected to drive the medical device manufacturing outsourcing market growth. For example, as per research conducted by UN (United Nations), in 2019, around 703 million people were of 65 years of age or over, across the globe. Furthermore, the number of aged people is expected to reach upto 1.5 billion (double) in 2050. Moreover,the massive growth in availability of healthcare and increasing number of patients across the globe are also driving the medical device manufacturing outsourcing market growth.

Download FREE Sample Copy of the Report at: https://www.researchdive.com/download-sample/165

In addition, the rapidly rising burden of chronic diseases worldwide, is also making positive impact on the growth of medical device manufacturing outsourcing market. For instance, As per data of WHO(World Health Organization), by 2020, the proportion of the burden of chronic disease like NCDs is anticipated to boost upto 57%, across the globe. On the other hand, the risk of leak of confidential data can be the obstruction to the growth of medical device manufacturing outsourcing market.

To meet the huge demand for healthcare emerging industries, the governments of china and India are focusing more on the enactment of policies such as “Healthy China 2030 Plan” and “National Health Protection Mission”. Also, rapid enhancements in the quality of healthcare sector in emerging economies are projected to generate huge opportunities of the medical device manufacturing outsourcing market. Developing countries such as India are projected to increase healthcare expenditure mainly because of extensively growing patients of non-communicable diseases (NCDs) diabetes and cancer. So these countries are emphasizing mainly on implementation of effective solutions and strategies to close gaps in healthcare industries. In addition, growing income and swiftly growing urbanization among these countries are projected to upsurge the medical device manufacturing outsourcing market.

The IVD(in-Vitro Diagnostic) device segment shall generate a revenue of$14.0 million by the end of 2026, increasing at a CAGR of 9.8%, over the forecast period.

The IVD (in-Vitro Diagnostic) devices segment has a significant market share over the projected period. Significantly increasing demand for early as well as accurate disease diagnosis, rising demand for FA instruments and automation in laboratories, and boosting adoption of PoC testing, are the major factors driving the medical device manufacturing outsourcing market. In addition, massive growth in the number of medical institutions in developing economies is also anticipated to generate noticeable revenue in this market.

The global device development and manufacturing services market has a highest market share, and it shall register a revenue of $35.6 million by 2026, increasing at a CAGR of 9.7%.The development and manufacturing services has the highest market share, over the projected period. High initial expenditure for in-house production of medical devices and positive growth in the medical device sector is expected to boost the development and manufacturing services segment growth.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/165

The class II medical devices segment shall register a revenue of $38.1 million by the end of 2026, increasing at a CAGR of 10.0%, during the forecast period. The class II medical device is specifically non-invasive and mainly consists of remote health care monitoring device, medical lasers, and many other devices. Also, significant contract medical device manufacturing companies like Cogmedix are supporting innovative companies to bring new class II devices to the global market.These factors are projected to surge the growth of medical device manufacturing outsourcing market.

The Asia-Pacific medical device manufacturing outsourcing market will cross $32.3 million by 2026, increasing at a healthy CAGR of 9.5%.

Asia-Pacific has the major share during the projected period mainly because of existance of a large base of chronic diseases cases, drastic developments in the technological knowledge, cost-effective labors. In addition, Asian economies like India, Japan and China have enormous market opportunities for pharmaceutical manufacturing. Also, the Korean based key players like Nissha Co., Ltd. are emphasizing majorly on a flexibility and customer-based service. These above mentioned factors are anticipated to boost the medical device manufacturing outsourcing market growth.

North America medical device manufacturing outsourcing market is the fastest growing market and it is expected to grow at a CAGR of 10.8% by generating revenue of $31.2 million by 2026. Tremendously rising demand for medical requirement, along with rising capital expenditure on healthcare are signifacant factors for boosting the North American medical device manufacturing outsourcing market growth. For example, according to American Medical Association, the U.S. has spent almost $3.5 trillion on the healthcare sector in 2017. These factors further drive the demand for medical devices, which eventually is going to surge the growth of medical device manufacturing outsourcing market in the North America region.

The major medical device manufacturing outsourcing market manufacturers are Creganna, Tecomet, Inc., Mitutoyo Corporation, FLEX LTD., Integer Holdings Corporation, Nortech Systems, Inc., Hamilton Company., DAIICHI JITSUGYO CO., LTD., Kinetics Climax Inc., andCirtec. To elaborate more on the competitive landscape analysis of top market players, the porter’s five force model is explained in this report.

Porter’s Five Forces Analysis for Medical device manufacturing outsourcing market:

• Bargaining Power of Suppliers: Established suppliers in the healthcare industry use their negotiating power to extract high prices. Moreover, the switching costs from one supplier to another supplier is projected to be high.
The bargaining power of suppliers is HIGH.

• Bargaining Power of Buyer: Hospitals and other healthcare institutions buy medical devicesin bulk quantities and apply pressure on pharmaceutical ventures to keep prices in check.
The bargaining power of consumers is MEDIUM.

• Threat of New Entrants: High cost associated with R&D along with government regulatory constraints provide slow threat of entry from new or potential competitors.
The threat of new entrants isLOW.

• Threat of Substitutes: The threat of a substitute product is high if it provides a value proposition that is significantly different from the present service of the market.
The threat of substitutes is LOW.

• Competitive Rivalry in the Market: Medical device manufacturing outsourcing market contains numerous small, medium, and large ventures. Leading enterprises are following alternative business strategies and technological advances among them is also a significant factor for the high competitive rivalry in the global market.
The competitive rivalry in the industry is HIGH.

Top Trending Reports in 2020-
♦ Computer-Aided Drug Discovery Market – https://www.researchdive.com/159/computer-aided-drug-discovery-market
♦ Intraoperative Neuromonitoring Market – https://www.researchdive.com/162/intraoperative-neuromonitoring-market
♦ Health and Wellness Market – https://www.researchdive.com/152/health-and-wellness-market

Contact Us:

How COVID-19 Pandemic Will Impact on Pneumonia Therapeutics Market Growth and Demand in 2020 and Coming Future?

The pneumonia therapeutics market is predicted to have a positive impact in 2020. Increasing cases of pneumococcal disease is predicted to drive the market in the forecast period. Pneumonia is mostly caused due to the infection in the lungs. At present the symptoms of coronavirus are most similar to that of pneumonia due to which most of the companies are focusing more on their research and development activities to launch new products to treat both the deadly diseases. For instance, in July 2020 NABRIVA received European approval for XENLETA (lefamulin) for treatment of community-acquired pneumonia (CAP). XENLETA is the first new antibiotic approved for patients with CAP in Europe. During this unpredicted situation, we are helping our clients in understanding the impact of COVID19 on the global market.

According to a study conducted by Research Dive, the global pneumonia therapeutics market is expected to register a revenue of $3,147.7 million till 2027, growing at a rate of 8.2% CAGR during, 2020-2027. The global market is classified on the basis of drug class, age group, and infection type and distribution channel. The report provides detailed information about drivers, opportunities, restraints, segmental analysis and competitive players of the market.

Factors Affecting the Market Growth

As per our analyst, increasing cases of pneumonia across the globe is predicted to be the major driving factor for the market in the projection period. Moreover, lack of awareness among the population about the pneumonia treatment is predicted to hinder the market growth in the forecast period.

Antiviral Drugs is Predicted to Have the Highest Market Share

On the basis of drug class, the pneumonia therapeutics market is further segmented into antifungal drugs, antiviral drugs and antibacterial drugs. Antiviral drugs is predicted to generate a revenue of $1,621.1 by 2027 with a CAGR of 8.6% in the projected timeframe. Pneumonia is a critical lung disorder which occurs mainly due to flu, several antiviral drugs helps to minimize the seriousness of the flu and helps in getting recover at a faster rate as compared to others medications due to which antiviral drugs segment is predicted to boost the overall market in the projected time frame.

Geriatric Segment is Predicted to Have Highest Growth Rate

On the basis of age group, the pneumonia therapeutics market is further segmented into geriatric, adult, and pediatric. Geriatric segment is predicted to generate a revenue of $1,215.0 by 2027 with a CAGR of 8.7% in the projected timeframe. Geriatric population has a weak immune system. There are high chances of being affected by pneumonia among the geriatric population due to which it is predicted to boost the segment in the forecast period.

Community-Acquired Pneumonia is Predicted to Grow Enormously

On the basis of infection type, the pneumonia therapeutics market is further segmented into ventilator-associated pneumonia (VAP), community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP). Community-acquired pneumonia segment is predicted to generate a revenue of $1,935.8 by 2027 with a CAGR of 8.5% in the projected timeframe. Community-acquired pneumonia generally occurs where people live in crowded places. Growing cases of community-acquired pneumonia especially in younger generation is predicted to boost the segment market in the forecast period.

Retail Pharmacies is Predicted to be the Most Lucrative Segment

On the basis of distribution channel, the pneumonia therapeutics market is further segmented into retail pharmacies, online pharmacies, and hospital pharmacies. Retail Pharmacies is predicted to generate a revenue of $1,284.2 by 2027 with a CAGR of 9.1% in the projected timeframe. The retail pharmacies segment is predicted to experience a boost due to the presence of large amount of brick and mortar store which gives a better advantage of accessibility, lower costs due to economies of scale and better services.

Regional Breakdown of the Market

On the basis of region, the pneumonia therapeutics market is further segmented into North America, Europe, Asia-Pacific and LAMEA. North America region market is predicted to generate a revenue of $1,023.0 by 2027 with a CAGR of 7.2% in the projected timeframe. Increasing geriatric population and presence of large number of pharmaceutical companies is predicted to drive the region market in the estimated time. Moreover, increasing research and development by majority of the companies is predicted to boost the region market in the forecast period

Top 9 Prominent players operating in the Global Pneumonia Therapeutics Market include:

1. Mylan
2. Novartis Lupin Pharmaceuticals
3. GlaxoSmithKline
4. Cipla
5. Abbott
6. Sanofi
7. Merck
8. Bayer
9. Allergan

Reference: https://www.researchdive.com/press-release/pneumonia-therapeutics-market.html

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

COVID-19 Impact: Which Are the Key Players Evolving In the Growth of Patient Handling Equipment Market?

Patient handling equipment market has been impacted positively due to the pandemic in the year 2020. As manual handling is not the best decision in this time of social distancing, the demand for patient handling equipment has been growing exponentially. Moreover, there is a risk of injury to the patient at the time of manual handling of beds while shifting patients from one place to another. Majority of the companies are focusing on developing new products for transferring patients. In March 2020, Invacare Corporation introduced a new brand of power wheelchairs. The launch of Invacare® AVIVA™ FX power wheelchair is predicted to strengthen the product portfolio of the company. During this unpredicted situation, we are helping our clients in understanding the impact of COVID19 on the global market.

According to a study conducted by Research Dive, the global patient handling equipment market is expected to register a revenue of $17.1 billion till 2027, growing at a rate of 8.5% CAGR during, 2020-2027. The global market is classified on the basis of product, application and end use. The report provides detailed information about drivers, opportunities, restraints, segmental analysis and competitive players of the market

Factors Affecting the Market Growth

As per our analyst, rise in the geriatric population and increasing cases of physical disability across the globe is predicted to be the major driving factor for the patient handling equipment market in the estimated timeframe. On the other hand lack of skilled labor is predicted to hinder the market in the estimated period.

Wheelchairs and Scooters Segment is Predicted to Have Highest Market Share

Depending on product, the patient handling equipment market is further classified as wheelchairs & scooters, mechanical lifting & transfer equipment, medical beds, bathroom safety supplies, ambulatory aid devices, and others. Wheelchairs and Scooters segment is predicted to grow with a CAGR of 9.4% by generating a revenue of $3.7 billion by 2027. Increase in the large number of physical disabilities among the population is predicted to boost the segment in the estimated timeframe.

Acute & Critical Care segment is predicted to Grow Enormously

Depending on application, the patient handling equipment market is further classified as long-term care, acute & critical care, fall prevention, mobility assistance and others. Acute & Critical Care segment is predicted to grow with a CAGR of 8.3% by generating a revenue of $5.9 billion by 2027. Increasing cases of chronic diseases among the population is predicted to drive the market in the forecast period.

Hospital Segment is predicted to have Highest Growth Rate

Depending on end use, the patient handling equipment market is further classified as hospitals, elderly care facilities, home care and settings and others. Hospitals segment is predicted to grow with a CAGR of 9.1% by generating a revenue of $5.7 billion by 2027. Hospital provides all the advanced features to the patients due to which it is predicted to drive the segment in the estimated timeframe.

Regional Breakdown of the Market

Depending on region, the patient handling equipment market is further classified as North America, Europe, Asia-Pacific and LAMEA. Asia-Pacific region market is predicted to grow with a CAGR of 9.2% by generating a revenue of $4.9 billion by 2027. Presence of large geriatric population, increasing healthcare infrastructures and rise in the chronic diseases is predicted to boost the region market in the forecast period.

Top 10 Prominent players operating in the Global Patient Handling Equipment Market include:

1. ORTHOS XXI
2. Antano Group
3. Drive Medical
4. Ossenberg
5. Prism Medical
6. Handicare
7. HoverTech International
8. Joerns Healthcare
9. Stiegelmeyer

Reference: https://www.researchdive.com/press-release/patient-handling-equipment-market.html

Contact Us:

Why Dynamics of Hand Sanitizer Market Is Changing Drastically? What If History Is Any Guide?

The communal transmission of COVID-19 has created a significant impact on the hand sanitizer market growth, throughout the projected timeframe. The growth of the global hand sanitizer market is mainly driven by the rising concern about personal safety among the customers. Furthermore, the extensively growing prevalence of viral disorders globally is also creating a huge demand for hand sanitizers, in the review period. Though the businesses across the globe have strictly imposed lockdown in order to reduce the impact of the pandemic spread, the global hand sanitizer industry has shown exponential growth.

The ventures involved with hand sanitizer production are adopting numerous strategic steps like product & technology advancements, strategic tie-ups. For example, in June 2020, Procter & Gamble (P&G), has made an announcement to launch of newly invented ‘safeguard sanitizer’. In addition, the enterprise is planning to raise its production capacity up to 45,000 liters of Safeguard hand sanitizer per week. Such adoption of development strategies by notable manufacturers is estimated to provide remarkable growth opportunities for the global hand sanitizer market, throughout the forecast timeframe.

According to the recently published report of Research Dive, the global hand sanitizer market is set to generate a revenue of $14,521.7 million by 2027, at a noteworthy CAGR of 24.2%, throughout the forecast timeframe. The segmentation of the market has been done on the basis of the product, distribution channel, and geographical region. The report offers detailed information about driving and restraining factors, future opportunities, vital segments, and industry players of the market.

Factors Affecting the Market Growth

As per our analyst estimates, the exponentially rising personal hygiene and safety concerns n the customers are expected to propel the growth of the global hand sanitizer market. Contrary to this, the health hazards associated with chemical ingredients are expected to restrain the growth of the hand sanitizer market, during the forecast timeframe.

The Gel-Based Hand sanitizer held the Substantial Market Share

Based on the product, the global hand sanitizer market is mainly divided into gel, foam, liquid, and others. The gel-based hand sanitizer segment will register a revenue of $8,161.2 million in 2027 and is anticipated to increase at CAGR of 24.6%; due to the cost-effectiveness and easy product availability.

The Online Distribution channel will have Exponential growth, Throughout the analysis Timeframe

Depending on the distribution channel, the global market for the hand sanitizer is majorly broadly categorized into a specialty store, hypermarket and supermarket, online, and drug store. The online distribution channel will reach up to $3,383.5 million by 2027 and is estimated to increase at a growth rate of 25.1%. The increasing influence of digital media, growing internet penetration in the developing economies like Brazil, India, and Mexico is predicted to foster the growth of the segment, throughout the forecast period

Geographical Analysis and Major Market Players

Depending on the geographical region, the global market for hand sanitizer is segmented into North America, Europe, Asia Pacific, and LAMEA. The Asia-Pacific hand sanitizer market will have a lucrative market growth and is valued at $3,949.9 million in 2027 at a 24.9% growth rate, over the forecast timeframe. The growth of the Asia-Pacific hand sanitizer market is mainly attributed to the growing prevalence of viral infectious disorders, the increasing emphasis on product development, and rising personal hygiene concerns mainly in India, China, and Australia countries.

Top 9 Prominent players operating in the Global Hand Sanitizer Market include:

1. The Himalaya Drug Company
2. Farouk Systems Inc.
3. Reckitt Benckiser Group plc.
4. Dr. Bronner’s Magic Soaps
5. Procter and Gamble
6. Best Sanitizers, Inc.
7. GOJO Industries, Inc.
8. Vi-Jon, Unilever.
9. Ningbo Jiangbei Ocean Star Factory & Trading Co., Ltd.

Reference: https://www.researchdive.com/press-release/hand-sanitizer-market.html

Contact Us:

The COVID-19 Fallout: Digital Health Market in 2020 - What Does the Year Ahead Hold?

The emergency of coronavirus has made a favorable impact on the global digital health market growth in 2020. During the emergency, COVID-19 has put the healthcare industry at a stage of rapid demand for telemedicine, online consultation and remote patient engagement for effective communication between doctors and patients. Also, increasing importance of home healthcare services is directly affecting the demand for digital health services owing to increasing consciousness among the people about the wide spread of the novel coronavirus. These factors are estimated to drive the market growth in the emergency time. Moreover, some of the government bodies are taking several activities to help the enterprises to endure in the crisis. For example, in recent times, the Infocomm Media Development Authority and Enterprise Singapore expanded the digitalization support for education and healthcare SMEs to manage the effect of the coronavirus. The learning management systems and tele-consultation solutions plan to offer education & healthcare providers to provide their services remotely. During this crisis, our analysts provide market players support in understanding the effect of COVID19 on the digital health market.

According to new study done by Research Dive, the global digital health market is expected to reach up to $1,045.8 million by 2027 and rising at a CAGR of 33.4% during the estimated time from 2020-2027. The global market is classified into technology, component and region. This study delivers comprehensive insights about drivers, opportunities, restraints, segmentation and top market players in the global market.

Factors affecting the market growth

As per our analysts, increasing trend for incorporation of artificial intelligence, internet of things and big data analytics to advance the digital healthcare is major driving factor for the growth of the market in the forecast years. However, huge implementation costs of the digital health services is predicted to be major restraint for the market growth.

Digital health systems technology and hardware segments held the global market size in previous decades-

Based on technology, the global market has been segmented into telehealthcare, health analytics, mHealth and digital health systems. Among these, digital health systems segment accounted for highest market size in 2019, it was valued at $52.7 billion and is estimated to rise at a healthy rate of 32.9% CAGR in the projected time. This dominance is majorly owing to growing government investments to promote digital health, which will drive the demand for digital health systems. Besides digital health systems, health analytics segment will witness to rise at a faster rate of 34.2% CAGR and is predicted to experience a potential growth in the forecast period.

The global digital health market has been categorized on the basis on component into software, services and hardware. In these, hardware segment generated majority of the digital health market share in the previous years, which was 38.0% and is predicted to account for $366.0 million by the end of 2027. This growth is due to rising geriatric population across the globe is expected to drive the demand for wearable medical devices like ECG monitors, BP monitors and fitness trackers. This factor will propel the market growth in the forecast time period. Services component is expected to grow at a significant rate of 33.9% CAGR during the forecast years. Increasing investments to improve healthcare digital infrastructures in the developed and developing economies is estimated to drive requirement of services to provide most efficient digital platforms.

Digital health market, Regional analysis

In 2019, the global digital health market has commanded by North America region and is predicted to generate a revenue of $360.8 million by the end of 2027. Wide utilization of digital health services across the North America due to swift growth in adoption of smart mobiles along with developments in coverage network systems. This factor is estimated to impel the market growth in the review period. Besides North America, Asia-Pacific will witness to grow at a faster rate of 34.2% CAGR in the forecast years and is predicted to create huge opportunities for market growth in the coming decades. This predicted rise credited to favorable government initiatives to support advancements in healthcare IT and increasing adoption of mHealth services across the Asia-Pacific region.

Top 10 Prominent players operating in the Global Digital Health Market include-

1. Allscripts Healthcare, LLC
2. CISCO
3. McKesson Corporation
4. AirStrip
5. Google Inc.
6. Koninklijke Philips N.V.
7. BioTelemetry, Inc.
8. Honeywell International Inc.
9. Cerner Corporation
10. Telefónica S.A.

Reference: https://www.researchdive.com/press-release/digital-health-market.html

Contact Us:

Corona Impact: Is Hearing Amplifiers Market will Propel with its Advanced Approaches in 2020

This pandemic of coronavirus has positively impacted the global hearing amplifiers market and is predicted to witness a considerable growth in the overall market in this outbreak. In the emergency of COVID-19, people are defending themselves by social distancing, wearing masks and washing their hands regularly. According to a new study conducted by Hearing Health Foundation, more than 87% of the people who have hearing disorders are facing difficulty in communication at this time. This difficulty is majorly due to protective masks covering half of the face, making it difficult to comprehend conversations. Face masks are making communication difficult for people relying on lip reading. Also, protective masks like N95 can also impact on sound levels by making sounds levels lower and more problematic to hear. These factors are creating more difficulties for people with hearing loss, which is predicted to drive the demand for hearing amplifiers during the pandemic period.

This study provides comprehensive insights about the impact of COVID-19 on global hearing amplifiers market.

As per new study done by Research Dive, the global hearing amplifiers market is expected to register for $108.0 billion revenue by 2027 and rising at a 5.9% CAGR throughout the forecast period from 2020 to 2027. The global market segmentation is done on the basis of product, distribution channel and region. This study intended to provide complete information about drivers, opportunities, restraints, segmentation and prominent players in the overall market.

Factors affecting the market growth

As per our analysts, growing geriatric population across the globe along with technological advancements in the hearing amplifiers are major driving factors for the growth of the market in the forecast period. Nevertheless, people are hesitant to wear due to social stigma is expected to limit the hearing amplifiers market growth.

Behind-the-ear products and hospital pharmacies segments accounted for significant market size in 2019

By product, the global market has been segmented into in-the-ear and behind-the-ear. In both of these, behind-the-ear segment accounted for highest hearing amplifiers market size, it was valued about $46.5 billion in 2019 and is expected to continue its command in the forecast years. Wide utilization of behind-the-ear amplifiers by the most of the consumers due to helps in improving hearing capability and suitable for all age groups. This factor is estimated to drive the market growth in the forecast years.

By distribution channel, the global market has been segmented into online pharmacies, hospital pharmacies and others. Among these, hospital pharmacies segment generated for largest market share of hearing amplifiers market in 2019 and is expected to account for $48.1 billion by the end of 2027, at a CAGR of 6.4%. The old aged people will prefer to purchase products from hospital pharmacies due to unaware of online pharmacies, which will drive the market growth in the forecast timeframe.

Hearing Amplifiers Market, Geographical insights

North America region has dominated the global hearing amplifiers market share, which was 32.0% in 2019 and is expected to generate a revenue of $33.7 billion till 2027. This dominance is majorly owing to rising frequency of hearing disorders across the region and government supports for technological advancements in the hearing amplifiers market. Besides North America, Asia-Pacific will witness to grow at a notable rate of 6.7% CAGR and is predicted to generate ample growth opportunities in the global market during the forecast timeframe. Growing healthcare expenditure and disposal income of individuals are estimated to fuel the market growth in the Asia-Pacific region.

Top 10 Prominent players operating in the Global Hearing Amplifiers Market include-

1. iHEAR Medical, Inc.
2. Etymotic Research, Inc.
3. MDHearingAid
4. SOUNDWORLD Solutions
5. FocusEar
6. IntriCon
7. Beurer
8. Otofonix
9. Amplifon
10. Britzgo.com

Reference: https://www.researchdive.com/press-release/hearing-amplifiers-market.html

Contact Us:

Home

Thursday, July 29, 2021

For More Detail Insights, Download FREE Sample Copy of the Report at: https://www.researchdive.com/download-sample/152

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/152

Porter’s Five Forces Analysis for Health and Wellness Market:

For More Detail Insights, Download FREE Sample Copy of the Report at: https://www.researchdive.com/download-sample/162

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/162

Porter’s Five Forces Analysis for Intraoperative Neuromonitoring Market:

Download FREE Sample Copy of the Report at: https://www.researchdive.com/download-sample/159

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/159

Porter’s Five Forces Analysis for Computer-Aided Drug Discovery Market:

Download FREE Sample Copy of the Report at: https://www.researchdive.com/download-sample/165

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/165

The Asia-Pacific medical device manufacturing outsourcing market will cross $32.3 million by 2026, increasing at a healthy CAGR of 9.5%.